We’re pleased to announce the two newest additions to the API board of directors: Jason Pincock and Greg Klak. Both are passionate leaders with extensive experience in the life sciences sector and will bring seasoned guidance to API as it grows and transforms the drug development industry in Alberta and beyond.
JASON PINCOCK, CEO, DYNALIFE
Jason is currently the Chief Executive Officer of DynaLIFE Medical Labs, one of Alberta’s largest private healthcare organizations. At over 1100 employees DynaLIFE is Canada’s most regarded multidisciplinary clinical laboratory organization and is recognized as one of Canada’s Best Managed Companies. Jason is a Certified Management Accountant, a graduate of the Queens Executive Program and a member of the Institute of Corporate Directors. Jason works with an ownership board, including OMERS and Laboratory Corporation of America (publicly traded) as well as a board of senior policy advisors.
GREG KLAK, VP AND GENERAL MANAGER, GILEAD
Greg Klak is the Vice President of Operations and General Manager for the Gilead Alberta site. Prior to the acquisition by Gilead in 2006, he spent 16 years with Raylo Chemicals providing custom manufacturing services to the pharmaceutical industry, including Gilead Sciences. Mr. Klak received both his B. Comm. and MBA degrees from the University of Alberta, and currently serves as a Board Member for BioAlberta.